[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-354378-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-354378-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","boron-neutron-capture-therapy-bnct-for-experimental-bladder-cancer-systemic-or-intravesical-approach","Boron Neutron Capture Therapy (BNCT) for experimental bladder cancer - systemic or intravesical approach","","Boron neutron capture therapy (BNCT) is investigated for its antitumoral and pro-inflammatory effects after systemic or intravesical borophenilalanine administration, and is compared with conventional radiotherapy (cRT) in an experimental bladder cancer model. Sixty-four Wistar rats were used, with bladder cancer induced in half. Tumour burden, proliferative and apoptotic indexes, and TNF-α–related inflammatory responses were assessed across bladder and perivesical tissues. Results show reduced tumour burden and generally lower inflammatory adverse findings with intravesical BNCT.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/boron-neutron-capture-therapy-bnct-for-experimental-bladder-cancer-systemic-or-intravesical-approach/354378/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/boron-neutron-capture-therapy-bnct-for-experimental-bladder-cancer-systemic-or-intravesical-approach/354378.png","ImageObject",300,407,{"name":42,"@type":43},"Aldword","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What question does the study aim to answer about BNCT?","Question",{"text":63,"@type":64},"It evaluates the antitumoral and pro-inflammatory effects of BNCT after systemic or intravesical borophenilalanine administration, and compares these outcomes with conventional radiotherapy in an experimental bladder cancer model.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were the animal experiments designed in this study?",{"text":68,"@type":64},"Sixty-four female Wistar rats were used, with half exposed to a carcinogen to induce bladder cancer. Radiation was delivered using the MARK TRIGA-II reactor for BNCT and via the Radiation Oncology division for cRT.",{"name":70,"@type":61,"acceptedAnswer":71},"What were the key findings regarding tumour burden and inflammation?",{"text":72,"@type":64},"Cancer-bearing animals showed a 15–30% decrease in tumour burden after radiotherapy. Intravesical BNCT was associated with lower proliferative and higher apoptotic indexes and a lower pro-inflammatory TNF-α response in bladder, with fewer pro-inflammatory adverse findings in perivesical tissues.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},354378,1790453603,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":115,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},2336478940917,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","British Journal of Cancer [www.nature.com/bjc](www.nature.com/bjc)  \nARTICLE OPEN   \nClinical Studies  \nBoron neutron capture therapy (BNCT) for experimental bladder cancer: systemic or intravesical approach  \nKerem Teke 1 ✉ , Cüneyt Özer2, Büşra Yaprak Bayrak3, İskender Atilla Reyhancan4, Çiğdem Vural3, Murat Kasap5,  \nAyşegül Ünal Karabey6, Gürler Akpınar5, Efe Bosnalı1, Neslihan Koyuncu4, İbrahim Erkut Avcı1, Onur Erbay4, Muhammet Sahip Kızıltaş4, Fatih Hunç7, Zeyneb Camtakan4, Önder Kara 1, Görkem Aksu6 and Özdal Dillioğlugil1  \n© The Author(s) 2026  \n\n|  | BACKGROUND: To investigate the antitumoral and pro-inﬂammatory effect of Boron Neutron Capture Therapy (BNCT) following systemic or intravesical borophenilalanine administration, and to compare it with conventional radiotherapy (cRT) in an experimental bladder cancer (BC) model.\u003Cbr>METHODS: Sixty-four Wistar rats were used, of which half were exposed to carcinogen to induce BC. Radiation therapy (RT) was performed both in the MARK TRIGA-II reactor for BNCT and in the Radiation Oncology divison for cRT. After necropsy, bladder and perivesical tissues were collected. Tumour staging, tumour burden, proliferative, and apoptotic indexes were evaluated for bladder samples. Bladder and perivesical tissues (colon, uterus, and anterior abdominal wall) were also assessed for inﬂammatory changes in H&E-stained sections, and also bladder TNF-α expressions was examined by immunohistochemistry and Western blot. RESULTS: The animals with cancer had a 15–30% decrease in tumour burden after RT. The incidence of persistent papillaryurothelial carcinoma was 100% in the Cancer-cRT group and 87.5% in the Cancer-BNCT-Sys group, whereas a lower incidence was observed in the Cancer-BNCT-IV group (71.4%) . A lower proliferative and a higher apoptotic indexes were observed in CancerBNCT-IV group compared to Cancer-cRT. Immunohistochemistry and Western blot for TNF-α expression showed that proinﬂammatory response in bladder was lower in BNCT-IV group among cancer treated groups. Moreover, there were lower proinﬂammatory adverse ﬁndings in perivesical tissues, including colon and uterus, in animals receiving BNCT-IV.\u003Cbr>CONCLUSION: Similar to cRT, systemic or intravesical BNCT resulted in a partial decrease in tumour burden, but fewer adverse |  |\n| --- | --- | --- |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| ﬁndings by intravesical borophenilalanine. |  |  |\n|  | British Journal of Cancer (2026) 135:223–231; [https://doi.org/10.1038/s41416-026-03418-w](https://doi.org/10.1038/s41416-026-03418-w) |  |\n|  |  |  |\n\nINTRODUCTION  \nBladder cancer is the seventh most common cancer globally and is one of the types of cancer with high mortality and morbidity [1] . Bladder cancer is categorised as localised (sub-divided into muscle invasive and non-muscle invasive) and metastatic. Radical cystectomy or chemoradiotherapy is recommended, especially for the treatment of non-metastatic muscle invasive disease. The European Urology Guidelines report that, although, the outcome of radiotherapy in non-muscle invasive bladder cancer is not clear, there is evidence of the positive effect of radiotherapy ononcological outcomes, especially in BCG-nonresponsive disease and in high-risk non-muscle invasive bladder cancer [2] .  \nRadiotherapy is often combined with transurethral resection and chemotherapy in muscle invasive bladder tumours, forming amultimodal treatment process and requires a multidisciplinary approach [3] . Although radiotherapy has antitumoral activity,  \ncomplications may include difﬁculty with urination due to the inﬂammatory side effects in the bladder and inﬂammation and adhesions in the perivesical tissues. Therefore, the risk of morbidity due to radiotherapy is increased, and salvage cystectomy after radiotherapy may even become quite complicated [4] .  \nMinimising vesical and perive","cbCaitXgMPdeE8UA","https://ap.wps.com/l/cbCaitXgMPdeE8UA","pdf",1785028,"English","# Background\n# Methods\n# Results\n# Conclusion\n# Introduction\n# Materials and Methods","[{\"question\":\"What question does the study aim to answer about BNCT?\",\"answer\":\"It evaluates the antitumoral and pro-inflammatory effects of BNCT after systemic or intravesical borophenilalanine administration, and compares these outcomes with conventional radiotherapy in an experimental bladder cancer model.\"},{\"question\":\"How were the animal experiments designed in this study?\",\"answer\":\"Sixty-four female Wistar rats were used, with half exposed to a carcinogen to induce bladder cancer. Radiation was delivered using the MARK TRIGA-II reactor for BNCT and via the Radiation Oncology division for cRT.\"},{\"question\":\"What were the key findings regarding tumour burden and inflammation?\",\"answer\":\"Cancer-bearing animals showed a 15–30% decrease in tumour burden after radiotherapy. Intravesical BNCT was associated with lower proliferative and higher apoptotic indexes and a lower pro-inflammatory TNF-α response in bladder, with fewer pro-inflammatory adverse findings in perivesical tissues.\"}]","Boron Neutron Capture Therapy (BNCT) for experimental bladder cancer - systemic or intravesical approach | PDF",1790110368,23,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/18d6eff012e61d9decc5e3da42547c31.webp",983,1305,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6afcc9801ee5b16acafcac4845a6bc8e.webp",982,1304,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5908cfb47217373726b9c2fef8551164.webp",981,1303,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6b26c5fb6d4b97ab23bb3d8c2d329633.webp",980,1301]